Gilder Gagnon Howe & Co’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.3M Sell
1,399,482
-434,209
-24% -$8.33M 0.34% 78
2026
Q1
$32.3M Sell
1,833,691
-23,448
-1% -$471K 0.39% 68
2025
Q4
$36.7M Sell
1,857,139
-26,937
-1% -$484K 0.39% 69
2025
Q3
$32.9M Buy
1,884,076
+1,738,449
+1,194% +$25.8M 0.34% 76
2025
Q2
$2.04M Buy
+145,627
New +$2.34M 0.02% 180

Other funds holding ALHC

Gilder Gagnon Howe & Co's ALHC Position: Q2 2026 in Review

Gilder Gagnon Howe & Co reduced its Alignment Healthcare (ALHC) stake by 24% in Q2 2026, selling an estimated $8.33M and leaving 1,399,482 shares worth $33.3M. The position accounts for 0.34% of the portfolio, ranked #78.

Gilder Gagnon Howe & Co first reported a position in ALHC in Q2 2025 and has held it in 5 quarters since. The position peaked at $36.7M in Q4 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Gilder Gagnon Howe & Co held 1,399,482 shares of Alignment Healthcare worth $33.3M as of Q2 2026.
  • Gilder Gagnon Howe & Co sold 434,209 Alignment Healthcare shares in Q2 2026, an estimated $8.33M.
  • Alignment Healthcare made up 0.34% of Gilder Gagnon Howe & Co's portfolio in Q2 2026, its #78 holding.
  • Gilder Gagnon Howe & Co first reported a position in Alignment Healthcare in Q2 2025 and has held it in 5 quarters since.
  • Gilder Gagnon Howe & Co's Alignment Healthcare position peaked at $36.7M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2026, filed 14 Aug 2026.